260 related articles for article (PubMed ID: 32493141)
1. Recommendations for treating life-threatening Kaposi sarcoma during pregnancy in HIV-positive women in low income countries.
Bacha JM; El-Mallawany NK; Slone JS; Wilkinson JP; Mehta PS; Campbell LR
Int J STD AIDS; 2020 Jul; 31(8):724-734. PubMed ID: 32493141
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial.
Krown SE; Moser CB; MacPhail P; Matining RM; Godfrey C; Caruso SR; Hosseinipour MC; Samaneka W; Nyirenda M; Busakhala NW; Okuku FM; Kosgei J; Hoagland B; Mwelase N; Oliver VO; Burger H; Mngqibisa R; Nokta M; Campbell TB; Borok MZ;
Lancet; 2020 Apr; 395(10231):1195-1207. PubMed ID: 32145827
[TBL] [Abstract][Full Text] [Related]
3. Assessing the outcomes of HIV-infected persons receiving treatment for Kaposi sarcoma in Conakry-Guinea.
Bekolo CE; Soumah MM; Tiemtore OW; Diallo A; Yuma JD; Di Stefano L; Metcalf C; Cisse M
BMC Cancer; 2017 Dec; 17(1):806. PubMed ID: 29197357
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
Stein ME; Lachter J; Spencer D; Bezwoda WR
Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
[TBL] [Abstract][Full Text] [Related]
5. Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy.
Núñez M; Saballs P; Valencia ME; Santos J; Ferrer E; Santos I; Berrocal A; Galindo MJ; Podzamczer D; Gonzlez-Lahoz J;
HIV Clin Trials; 2001; 2(5):429-37. PubMed ID: 11673818
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes of AIDS-associated Kaposi's sarcoma under a routine antiretroviral therapy program in Lilongwe, Malawi: bleomycin/vincristine compared to vincristine monotherapy.
Mwafongo AA; Rosenberg NE; Ng'ambi W; Werner AB; Garneau WM; Gumulira J; Phiri S; Hosseinipour MC
PLoS One; 2014; 9(3):e91020. PubMed ID: 24632813
[TBL] [Abstract][Full Text] [Related]
7. Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal.
Goebel FD; Jablonowski H
Eur J Med Res; 1999 Dec; 4(12):507-13. PubMed ID: 10611054
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Kaposi sarcoma in children with HIV-1 infection.
Anglemyer A; Agrawal AK; Rutherford GW
Cochrane Database Syst Rev; 2014 Jan; (1):CD009826. PubMed ID: 24464843
[TBL] [Abstract][Full Text] [Related]
9. As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial.
Hosseinipour MC; Kang M; Krown SE; Bukuru A; Umbleja T; Martin JN; Orem J; Godfrey C; Hoagland B; Mwelase N; Langat D; Nyirenda M; MacRae J; Borok M; Samaneka W; Moses A; Mngqbisa R; Busakhala N; Martínez-Maza O; Ambinder R; Dittmer DP; Nokta M; Campbell TB;
Clin Infect Dis; 2018 Jul; 67(2):251-260. PubMed ID: 29365083
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa.
Mosam A; Shaik F; Uldrick TS; Esterhuizen T; Friedland GH; Scadden DT; Aboobaker J; Coovadia HM
J Acquir Immune Defic Syndr; 2012 Jun; 60(2):150-7. PubMed ID: 22395672
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Outcomes in AIDS-Associated Kaposi's Sarcoma Patients on Antiretroviral Therapy Treated with Chemotherapy at Two Tertiary Hospitals in Lusaka, Zambia.
Mtonga W; Mujajati A; Munkombwe D; Kalungia A; Muungo LT; West J; Wood C; Ngalamika O
Curr HIV Res; 2018; 16(3):231-236. PubMed ID: 29992888
[TBL] [Abstract][Full Text] [Related]
12. Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi.
Herce ME; Kalanga N; Wroe EB; Keck JW; Chingoli F; Tengatenga L; Gopal S; Phiri A; Mailosi B; Bazile J; Beste JA; Elmore SN; Crocker JT; Rigodon J
J Int AIDS Soc; 2015; 18(1):19929. PubMed ID: 26028156
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis.
Freeman EE; McCann NC; Semeere A; Reddy KP; Laker-Oketta M; Byakwaga H; Pei PP; Hajny Fernandez ME; Kiprono S; Busakhala N; Martin JN; Maurer T; Bassett IV; Freedberg KA; Hyle EP
Lancet Glob Health; 2022 Aug; 10(8):e1179-e1188. PubMed ID: 35839816
[TBL] [Abstract][Full Text] [Related]
14. Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study.
El-Mallawany NK; Kamiyango W; Slone JS; Villiera J; Kovarik CL; Cox CM; Dittmer DP; Ahmed S; Schutze GE; Scheurer ME; Kazembe PN; Mehta PS
PLoS One; 2016; 11(4):e0153335. PubMed ID: 27082863
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma in pregnancy after initiation of highly active antiretroviral therapy: a manifestation of immune reconstitution syndrome.
Adeyemo A; Wood C; Govind A
Int J STD AIDS; 2012 Dec; 23(12):905-6. PubMed ID: 23258835
[TBL] [Abstract][Full Text] [Related]
16. Treatment and outcome of AIDS-related Kaposi sarcoma in South Africa, Malawi and Zambia: an international comparison.
Rohner E; Kasaro M; Msadabwe-Chikuni SC; Stinson K; Mohamed Z; Tweya H; Egger M; Bohlius J
Pan Afr Med J; 2017; 28():261. PubMed ID: 29881504
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma.
Volkow P; Cesarman-Maus G; Garciadiego-Fossas P; Rojas-Marin E; Cornejo-Juárez P
AIDS Res Ther; 2017 May; 14(1):30. PubMed ID: 28558783
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of chemotherapeutics in classic and non-classic Kaposi sarcoma: A single-center retrospective real-world data.
Oyucu Orhan S; Bilgehan Sahin A; Cubukcu E; Deligonul A; Ocak B; Orhan B; Evrensel T
Bosn J Basic Med Sci; 2021 Dec; 21(6):746-751. PubMed ID: 33596402
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma: Good outcome with doxorubicin, bleomycin and vincristine sulphate (ABV) chemotherapy and highly active antiretroviral therapy.
Hesseling PB; Katayi E; Wharin P; Bardin R; Kouya F; Palmer D; Glenn M; Kruger M
S Afr Med J; 2017 Oct; 107(11):952-953. PubMed ID: 29262935
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of an HIV-positive patient with unmasking Kaposi's sarcoma immune reconstitution inflammatory syndrome.
Speicher DJ; Sehu MM; Johnson NW; Shaw DR
J Clin Virol; 2013 Jul; 57(3):282-5. PubMed ID: 23578530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]